Inmagene Biopharmaceuticals
Biotechnology Research · 11 Employees
Email Address: public.relations@inmagenebio.com
- Overview
- Employees
Access 29 Verified Employees Profiles for Inmagene BiopharmaceuticalsUnlock Free Contacts Now
About
Inmagene is a global clinical-stage biotechnology company developing novel therapeutics for I&I diseases. The company’s highly differentiated clinical-stage pipeline has multiple candidates with best-in-class potential. The lead asset IMG-007, a non-depleting anti-OX40 mAb, is in two global Phase 2a clinical trials in atopic dermatitis and alopecia areata. IMG-004, a non-covalent reversible BTK inhibitor is in a Phase 1 multiple ascending dose (MAD) study. IMG-008, an in-house developed long-acting anti-IL-36R mAb is entering global Phase 1 clinical development.
Website
Year Founded
2019
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
12526 High Bluff Drive, Suite 345
San Diego, CA 92130, US
Keywords
immunologyinflammatiobiotechnologyOX40BTKIL-36RI&I
Location
4
- 12526 High Bluff Drive, Suite 345 San Diego, CA 92130, US
Email Formats
Sign up for free credits and discover verified email addresses of Inmagene Biopharmaceuticals
FormatExamples
first + last
andywarhol@inmagenebio.com
first_initial + last
awarhol@inmagenebio.com
first + last_initial
andyw@inmagenebio.com
first
andy@inmagenebio.com
last
warhol@inmagenebio.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Inmagene Biopharmaceuticals and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.